Tempest Therapeutics, Inc. Net Cash Provided by (Used in) Operating Activities, Continuing Operations
Tempest Therapeutics, Inc. (TPST) reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of -$14.39 million for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-05-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2015-05-11
- Tempest Therapeutics, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2015-03-31 was -$14.39M.
- Tempest Therapeutics, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2014-12-31 was -$10.52M.
- Tempest Therapeutics, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2014-09-30 was -$8.54M.
- Tempest Therapeutics, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2014-06-30 was -$6.57M.
- Tempest Therapeutics, Inc. net cash provided by (used in) operating activities, continuing operations for fiscal 2014 was -$30.59M.
- Tempest Therapeutics, Inc. net cash provided by (used in) operating activities, continuing operations for fiscal 2013 was -$18.09M.
- Tempest Therapeutics, Inc. net cash provided by (used in) operating activities, continuing operations for fiscal 2012 was -$11.16M.
| Period end | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 15 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 18 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 21 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 24 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 27 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 30 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 33 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 36 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015-03-31 | -$14.39M 10-Q · filed 2015-05-11 | -$24.92M derived: sum of 2 quarters · filed 2015-05-11 | -$33.45M derived: sum of 3 quarters · filed 2015-05-11 | -$40.02M derived: sum of 4 quarters · filed 2015-05-11 | ||||||||
| 2014-12-31 | -$10.52M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | -$19.06M derived: sum of 2 quarters · filed 2015-03-16 | -$25.63M derived: sum of 3 quarters · filed 2015-03-16 | -$30.59M 10-K · filed 2015-03-16 | ||||||||
| 2014-09-30 | -$8.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$15.10M derived: sum of 2 quarters · filed 2014-11-10 | -$20.06M 10-Q · filed 2014-11-10 | -$24.75M derived: sum of 4 quarters · filed 2015-05-11 | ||||||||
| 2014-06-30 | -$6.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$11.53M 10-Q · filed 2014-08-07 | -$16.22M derived: sum of 3 quarters · filed 2015-05-11 | -$20.40M derived: sum of 4 quarters · filed 2015-05-11 | ||||||||
| 2014-03-31 | -$4.96M 10-Q · filed 2015-05-11 | -$9.65M derived: sum of 2 quarters · filed 2015-05-11 | -$13.84M derived: sum of 3 quarters · filed 2015-05-11 | -$19.00M derived: sum of 4 quarters · filed 2015-05-11 | -$35.77M 10-Q · filed 2014-05-08 | |||||||
| 2013-12-31 | -$4.69M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | -$8.87M derived: sum of 2 quarters · filed 2015-03-16 | -$14.04M derived: sum of 3 quarters · filed 2015-03-16 | -$18.09M 10-K · filed 2015-03-16 | -$30.81M 10-K · filed 2014-02-27 | |||||||
| 2013-09-30 | -$4.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$9.35M derived: sum of 2 quarters · filed 2014-11-10 | -$13.41M 10-Q · filed 2014-11-10 | -$16.89M derived: sum of 4 quarters · filed 2015-03-16 | -$26.12M 10-Q · filed 2013-11-13 | |||||||
| 2013-06-30 | -$5.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$9.22M 10-Q · filed 2014-08-07 | -$12.70M derived: sum of 3 quarters · filed 2015-03-16 | -$15.64M derived: sum of 4 quarters · filed 2015-03-16 | -$21.94M 10-Q · filed 2013-08-13 | |||||||
| 2013-03-31 | -$4.06M 10-Q · filed 2014-05-08 | -$7.54M derived: sum of 2 quarters · filed 2015-03-16 | -$10.48M derived: sum of 3 quarters · filed 2015-03-16 | -$14.39M derived: sum of 4 quarters · filed 2015-03-16 | -$16.77M 10-Q · filed 2013-05-15 | |||||||
| 2012-12-31 | -$3.48M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | -$6.42M derived: sum of 2 quarters · filed 2015-03-16 | -$10.34M derived: sum of 3 quarters · filed 2015-03-16 | -$11.16M 10-K · filed 2015-03-16 | -$12.72M 10-K · filed 2013-02-25 | |||||||
| 2012-09-30 | -$2.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | -$6.85M derived: sum of 2 quarters · filed 2013-11-13 | -$7.67M 10-Q · filed 2013-11-13 | -$9.23M 10-Q · filed 2012-11-13 | ||||||||
| 2012-06-30 | -$3.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | -$4.74M 10-Q · filed 2013-08-13 | -$6.30M 10-Q · filed 2012-08-14 | |||||||||
| 2012-03-31 | -$818.00K 10-Q · filed 2013-05-15 | |||||||||||
| 2011-12-31 | -$1.56M 10-K · filed 2014-02-27 | |||||||||||
| 2011-09-30 | -$515.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-11-13 | -$510.00K 10-Q · filed 2012-11-13 | ||||||||||
| 2011-06-30 | $5.00K 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |